BF
SAGE

BOK Financial’s Sage Therapeutics SAGE Stock Holding History

BOK Financial’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,933
Closed -$547K – 935
2022
Q2 		$547K Sell
16,933
-134
-0.8% -$4.49K 0.01% 662
2022
Q1 		$565K Buy
17,067
+1,285
+8% +$48.3K 0.01% 707
2021
Q4 		$671K Sell
15,782
-1,457
-8% -$61K 0.01% 668
2021
Q3 		$764K Buy
+17,239
New +$791K 0.01% 630
2020
Q1 		– Sell
-10,283
Closed -$742K – 912
2019
Q4 		$742K Buy
+10,283
New +$1.26M 0.02% 599
2019
Q3 		– Sell
-1,112
Closed -$203K – 937
2019
Q2 		$203K Buy
+1,112
New +$190K ﹤0.01% 857

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BOK Financial's SAGE Position: Q3 2022 in Review

BOK Financial sold out of Sage Therapeutics (SAGE) in Q3 2022, closing a stake of 16,933 shares — an estimated $547K sold.

BOK Financial first reported a position in SAGE in Q2 2019 and held it in 6 quarters. The position peaked at $764K in Q3 2021. 200 funds tracked by Wall St. Rank hold SAGE as of Q3 2022.

  • BOK Financial reported no remaining Sage Therapeutics position as of Q3 2022 after selling out during the quarter.
  • BOK Financial sold 16,933 Sage Therapeutics shares in Q3 2022, an estimated $547K.
  • BOK Financial first reported a position in Sage Therapeutics in Q2 2019 and held it in 6 quarters.
  • BOK Financial's Sage Therapeutics position peaked at $764K in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2022.

Based on BOK Financial's 13F filing for Q3 2022, filed 14 Nov 2022.